US Appeals Court Says No to Teva’s Generic Evista

Eli Lilly & Co. won a patent battle protecting its osteoporosis drug Evista Wednesday, as an appeals court declined to toss out a permanent injunction preventing production of a generic copy of the medicine.
CNNMoney